• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Concerning the use of aminoglycosides in ventilator-associated pneumonia - Authors' reply.

作者信息

Chhabra Srishti, Mo Yin

机构信息

Division of Infectious Diseases, Department of Medicine, National University Hospital, Singapore 119074.

Division of Infectious Diseases, Department of Medicine, National University Hospital, Singapore 119074; ADVANCE-ID, Saw Swee Hock School of Public Health, National University of Singapore, Singapore; Infectious Diseases Translational Research Program, National University of Singapore, Singapore; Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Centre for Tropical Medicine, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

出版信息

Lancet Respir Med. 2024 Aug;12(8):e46. doi: 10.1016/S2213-2600(24)00206-6.

DOI:10.1016/S2213-2600(24)00206-6
PMID:39089762
Abstract
摘要

相似文献

1
Concerning the use of aminoglycosides in ventilator-associated pneumonia - Authors' reply.关于氨基糖苷类药物在呼吸机相关性肺炎中的应用——作者回复。
Lancet Respir Med. 2024 Aug;12(8):e46. doi: 10.1016/S2213-2600(24)00206-6.
2
Concerning the use of aminoglycosides in ventilator-associated pneumonia.
Lancet Respir Med. 2024 Aug;12(8):e45. doi: 10.1016/S2213-2600(24)00207-8.
3
An Argument for the Use of Aminoglycosides in the Empiric Treatment of Ventilator-Associated Pneumonia.关于在呼吸机相关性肺炎经验性治疗中使用氨基糖苷类药物的观点
Surg Infect (Larchmt). 2016 Jun;17(3):329-33. doi: 10.1089/sur.2015.276. Epub 2016 Apr 1.
4
Inhaled aminoglycosides in cancer patients with ventilator-associated Gram-negative bacterial pneumonia: safety and feasibility in the era of escalating drug resistance.吸入性氨基糖苷类药物用于患有呼吸机相关性革兰氏阴性菌肺炎的癌症患者：在耐药性不断升级时代的安全性和可行性
Eur J Clin Microbiol Infect Dis. 2009 Mar;28(3):253-9. doi: 10.1007/s10096-008-0620-5. Epub 2008 Aug 28.
5
Ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: understanding nebulization of aminoglycosides and colistin.多重耐药革兰氏阴性菌引起的呼吸机相关性肺炎：了解氨基糖苷类和黏菌素的雾化吸入
Intensive Care Med. 2020 Apr;46(4):766-770. doi: 10.1007/s00134-019-05890-w. Epub 2020 Jan 8.
6
The ATTAIN trials: efficacy and safety of telavancin compared with vancomycin for the treatment of hospital-acquired and ventilator-associated bacterial pneumonia.ATTAIN试验：替考拉宁与万古霉素治疗医院获得性和呼吸机相关性细菌性肺炎的疗效与安全性比较
Future Microbiol. 2014;9(3):281-9. doi: 10.2217/fmb.14.4. Epub 2014 Jan 22.
7
The authors reply.
Crit Care Med. 2016 May;44(5):e304-5. doi: 10.1097/CCM.0000000000001589.
8
Aerosolized antibiotics for treating hospital-acquired and ventilator-associated pneumonia.雾化抗生素治疗医院获得性肺炎和呼吸机相关性肺炎。
Expert Rev Anti Infect Ther. 2011 Nov;9(11):993-1000. doi: 10.1586/eri.11.126.
9
The role of telavancin in hospital-acquired pneumonia and ventilator-associated pneumonia.替考拉宁在医院获得性肺炎和呼吸机相关性肺炎中的作用。
Clin Infect Dis. 2015 Sep 15;61 Suppl 2:S79-86. doi: 10.1093/cid/civ535.
10
The authors reply.作者回复。
Crit Care Med. 2014 Nov;42(11):e726-7. doi: 10.1097/CCM.0000000000000599.

引用本文的文献

1
Identification and validation of robust hospital-acquired pneumonia subphenotypes associated with all-cause mortality: a multi-cohort derivation and validation.与全因死亡率相关的医院获得性肺炎稳健亚表型的识别与验证：多队列推导与验证
Intensive Care Med. 2025 Apr;51(4):692-707. doi: 10.1007/s00134-025-07884-3. Epub 2025 Apr 22.